Versant Venture Management as of March 31, 2025
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 7 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Monte Rosa Therapeutics Common Stock (GLUE) | 43.6 | $26M | 5.7M | 4.64 | |
| CRISPR Therapeutics Common Shares (CRSP) | 28.2 | $17M | 499k | 34.03 | |
| Contineum Therapeutics Common Stock (CTNM) | 10.6 | $6.4M | 918k | 6.98 | |
| Skye Bioscience Common Stock (SKYE) | 5.3 | $3.2M | 2.0M | 1.59 | |
| Repare Therapeutics Common Stock (RPTX) | 4.3 | $2.6M | 2.6M | 0.99 | |
| Tempest Therapeutics Common Stock (TPST) | 4.3 | $2.6M | 3.5M | 0.74 | |
| Adverum Biotechnologies Common Stock | 3.7 | $2.2M | 507k | 4.37 |
